Skip to content

Comparison between two analgesic protocols in Femoral fracture on one cardiac indicator

Comparison between the levels of N-Terminal Pro B-Type Natriuretic Peptide in surgeries of Femoral Shaft Fracture by two types of Patient Controlled Epidural and Intravenous Analgesia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT138903084046N1
Enrollment
80
Registered
2011-05-10
Start date
2011-04-03
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Epidural and Intravenous Analgesia. Anaesthetic, unspecified

Interventions

Intervention 1: Epidural groups will have epidural catheter through L3-4 or L4-5. Epidural group will have bupivacaine 0.125%, 5-8 ml epidural after operation till their VAS become less than 3. Interv
Treatment - Other
Treatment - Drugs
Epidural groups will have epidural catheter through L3-4 or L4-5. Epidural group will have bupivacaine 0.125%, 5-8 ml epidural after operation till their VAS become less than 3.
Intravenous group will have 2 mg of intra venous morphine every 10 minutes till VAS score reaches less than 3 and after that they will receive morphine 0.5% 4-8 cc/h intravenously. If the patient fill

Sponsors

Shahid Beheshti University of Medical Science.Anesthesiology research centre
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 65 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: patients are between 20-65 and will have elective surgery of femoral fracture.The ASA class of them are I and II . Exclusion criteria:Any history of renal or cardiac problem and drug abuse or Operation more than 3 hours and bleeding more than 1 liter and serum injection more than 4 litres are of another exclusion criteria .

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
B type Natriuretic Peptide. Timepoint: pre and 24 hours after operation. Method of measurement: lab Kit.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAlireza Mirkheshti

Imam Hossein Hospital

a_mirkheshti@sbmu.ac.iralimirkheshti@yahoo.com+98 21 7756 7840

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026